Pharvaris (PHVS) Gross Profit (2025 - 2026)
Pharvaris (PHVS) posted Gross Profit of $85,072 for Q2 2026, down 89.7% from $828,364 a year earlier and down 4.2% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Gross Profit (2025 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Pharvaris was -$229,224.
- The Q2 2026 figure stands as the lowest quarterly Gross Profit since Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Pharvaris | 2.03 Bn | -289,124.37 Bn | 85,072.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85,072.10 |
| Mar 31, 2026 | 88,772.96 |
| Jun 30, 2025 | 828,363.57 |
| Mar 31, 2025 | -1.23 Mn |
API Access
Pharvaris Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();